As of Feb 24
| +0.54 / +0.69%|
The 16 analysts offering 12-month price forecasts for DexCom Inc have a median target of 91.00, with a high estimate of 105.00 and a low estimate of 59.00. The median estimate represents a +15.92% increase from the last price of 78.50.
The current consensus among 17 polled investment analysts is to Buy stock in DexCom Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.